Liberty Leaf Holdings Ltd. is a publicly traded company in the business of acquiring partnership interests in up-and-coming and established companies in the medicinal and recreational cannabis space. The Company operates in Canada and is actively seeking to enter the various legal cannabis markets in North America. Our shares are traded internationally.
We invest strategically in companies that are established, proven performers. Then we provide funding, management, HR resources, and marketing expertise to help those companies thrive and accelerate their growth. We also form working relationships with organizations engaged in research and development of cannabis uses and products and use the knowledge gained from them to help our business expand and develop new markets.
Liberty Leaf’s objective is to be at the forefront of the Cannabis industry, accelerating revenue generating businesses within this fast growing sector.
Our strategy for getting there
Strategically connect with individuals, industry leaders and companies.
Focus entirely on the fast growing Cannabis sector with the overall goal of creating shareholder value.
Use our expertise in marketing to strengthen brands, nurture customer loyalty and connect vertical distribution platforms to excel and exceed revenue growth projections.
Unlike other cannabis companies, we exist not to grow product, but to grow companies in this space. Since we invest in existing, well-established and profitable companies, we can focus our time and resources on helping them grow to become even more profitable. As an investor, you benefit from our expertise as an accelerator of companies with a proven ability to generate revenues and increase shareholder values.
If you are a company in the legal cannabis space, we can be that rare, strategic partner that can actually accelerate your success by providing management, marketing, relevant industry contacts and other business expertise.
Liberty Leaf Holdings Ltd. (CSE: LIB, OTCQB: LIBFF and FSE: HN3P) (the “Company” or “Liberty Leaf”) announced today it has received an aggregate $763,500 from the exercise of share purchase warrants. A total of 10,180,000 warrants were exercised at $0.075 and the Company issued a total ...
Liberty Leaf is taking an active role in advancing research into veterinary cannabis use with its three-year collaborative agreement with ESEV, a leading Israeli-American research and development company. Liberty Leaf has appointed Ms. Fitzpatrick to ...
has submitted a significant abridgement to its Access to Cannabis for Medical Purposes Regulations (ACMPR) application currently in review by Health Canada.